Compare ARMOUR Residential REIT, Inc. (ARR) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARMOUR Residential REIT, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? ARMOUR Residential REIT, Inc. trades at $16.72 (market cap $2.07B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: ARMOUR Residential REIT, Inc. is far larger — about 26.4× Inovio Pharmaceuticals Inc's market cap, and ARMOUR Residential REIT, Inc. pays a 17.28% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ARR | INO | |
|---|---|---|
Market Cap | $2.07B | $78.55M |
Sector | Financials | Health |
52-Week High | $19.12 | $2.87 |
52-Week Low | $14.05 | $0.66 |
Dividend Yield | 17.28% | — |
Enterprise Value | — | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARMOUR Residential REIT, Inc.
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
Read more on ARR →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
